Kala Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
45.88
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
10.75
|
19.25
|
8.50
|
79.07%
|
|
2022-06-30
|
-21.75
|
-19.00
|
2.75
|
12.64%
|
|
2022-03-31
|
-17.87
|
-22.50
|
-4.63
|
-25.91%
|
|
2021-12-31
|
-20.33
|
-34.00
|
-13.67
|
-67.24%
|
|
2021-09-30
|
-21.50
|
-21.50
|
0.00
|
0.00%
|
|
2021-06-30
|
-22.00
|
-28.50
|
-6.50
|
-29.55%
|
|
2021-03-31
|
-34.21
|
-24.50
|
9.71
|
28.38%
|
|
2020-12-31
|
-22.92
|
-27.50
|
-4.58
|
-19.98%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-22.25
|
|
2021-12-31
|
-108.50
|
|
2020-12-31
|
-53.46
|
|
2019-12-31
|
-2.76
|
|
2018-12-31
|
-2.45
|
|
2017-12-31
|
-10.90
|